Colleen Doyle

Senior Director Risks, Insight, and Management at Novo Nordisk

Speaker

Colleen Doyle is the Senior Director of Risk Insights and Management at Novo Nordisk. She leads Compliance Training, Auditing, Monitoring and Investigations. Prior to Novo, Colleen led Sage Therapeutic’s Enterprise Risk Management program, Compliance Audits and Corporate Investigations. She also worked in various roles in the pharmaceutical industry, including Internal Audit, Quality Assurance, Marketing and FP&A.

She began her career at KPMG in New York’s Audit and Forensic practices, performing financial statement audits, investigations and fraud risk management assessments.

Colleen is a Certified Internal Auditor and Certified Fraud Examiner.